| 发明名称 | Methods for treating HCV | ||
| 摘要 | This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions. | ||
| 申请公布号 | US9452154(B2) | 申请公布日期 | 2016.09.27 |
| 申请号 | US201414513900 | 申请日期 | 2014.10.14 |
| 申请人 | Gilead Sciences, Inc. | 发明人 | Delaney, IV William E.;Link John O.;Mo Hongmei;Oldach David W.;Ray Adrian S.;Watkins William J.;Yang Cheng Yong;Zhong Weidong |
| 分类号 | A61K31/675;A61K31/4184;A61K31/381;A61K31/40;A61K31/401;A61K31/4025;A61K31/407;A61K31/4178;A61K31/4188;A61K31/4353;A61K31/4436;A61K31/662;A61K31/7056;A61K45/06;A61K31/501;A61K31/5377;A61K38/21;A61K31/706 | 主分类号 | A61K31/675 |
| 代理机构 | Sheppard Mullin Richter & Hampton LLP | 代理人 | Sheppard Mullin Richter & Hampton LLP |
| 主权项 | 1. A composition comprising Compound 1 having the structureor a pharmaceutically acceptable salt thereofand Compound 5 having the structureor a pharmaceutically acceptable salt thereof. | ||
| 地址 | Foster City CA US | ||